BioCentury
ARTICLE | Company News

Actavis, TPG Capital deal

February 16, 2015 8:00 AM UTC

Actavis will divest its Aptalis Pharmaceutical Technologies outsourcing and R&D business to private investment firm TPG for an undisclosed sum. The deal is expected to close by mid-year. Actavis said ...